ASX:CPH

Creso Pharma Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive CPH News and Ratings via Email

Sign-up to receive the latest news and ratings for Creso Pharma and its competitors with MarketBeat's FREE daily newsletter.


About Creso Pharma

Creso Pharma Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and animal health in Europe, the Middle East, North America, and the Asia Pacific. The company develops and commercializes therapeutic products; and cultivates and harvests cannabis plants, as well as supplies dried cannabis plant retail products. Its products include anibidiol, a complementary feed product for companion animals; cannaQIX, a nutraceutical product containing hemp oil extract, and vitamins and zinc that reduces stress and supports psychological and nervous functions in humans; and topical and skin care products, which include cannaDOL, a CBD-based topical gel associated with a mixture of cooling and warming essential oils. The company also offers nutraceutical products, such as cannaQIX, a hemp oil-derived food supplement under the Cannamics brand. Creso Pharma Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.17 out of 5 stars

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Creso Pharma (ASX:CPH) Frequently Asked Questions

What stocks does MarketBeat like better than Creso Pharma?

Wall Street analysts have given Creso Pharma a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Creso Pharma wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Creso Pharma's key executives?

Creso Pharma's management team includes the following people:
  • Mr. Adam Blumenthal B.Com., M.B.A., Co-Founder & Non-Exec. Chairman
  • Mr. Boaz Wachtel M.A., M.D., MBA, Co-Founder & Non-Exec. Director (Age 60, Pay $77.5k)
  • Mr. Christopher Grundy, Chief Financial Officer
  • Dr. James Anthony Ellingford M.B.A., Ph.D., PG(Corp Mgmt), D.Mgt, MBA, AICD, Exec. Director
  • Dr. Gian Trepp, Commercial & Marketing Director
  • Ms. Erlyn Saromines Dale A.C.I.S., B.Com., BCom., GradDipACG, AGIA, ACIS, Joint Company Sec.
  • Mr. Winton William Willesee BBus, BBus., CPA, DipEd, DipEd., PGDipBus, PGDi, Joint Company Sec.
  • Dr. Simon H. W. Buckingham, Consultant (Age 59)

Who are some of Creso Pharma's key competitors?

What is Creso Pharma's stock symbol?

Creso Pharma trades on the ASX under the ticker symbol "CPH."

How much money does Creso Pharma make?

Creso Pharma has a market capitalization of $0.00 and generates $4.03 million in revenue each year.

What is Creso Pharma's official website?

The official website for Creso Pharma is www.cresopharma.com.

How can I contact Creso Pharma?

The company can be reached via phone at 61 2 8067 8606.


This page was last updated on 9/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.